Feb 5 (Reuters) - Medtronic (MDT.N), opens new tab owes rival medical device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for blood-vessel ...

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the ...

Abstract: With the development of the medical service industry, traditional centralized medical device traceability management systems are becoming inadequate for current demands. To address the ...

Hands-on research and applied technology experiences prepare University of New Haven students for careers in high-demand innovation sectors. The University of New Haven has entered into a master ...

Resolution Medical’s devices are for medical technology end markets including structural heart, cardiology and vascular, electrophysiology, and neuromodulation therapies Resolution Medical was founded ...

Sure, you’ve heard it all before — how artificial intelligence (AI) is transforming design and development and the production process across the board, and that companies that don’t embrace the ...

As medical device manufacturers face mounting pressures to reduce environmental risk, improve traceability, and accelerate product development, Americhem is preparing to highlight a suite of new ...

Americhem to Spotlight New Materials Addressing PFAS, Traceability, and Performance Demands in Medical Devices at Pharmapack and MD&M West 2026 As medical device manufacturers face mounting pressures ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Mario Aguilar covers technology ...

The FDA said it plans to accept new forms of real-world evidence in product applications, starting with a subset of medical device submissions. The agency said the policy change aims to enable the use ...

The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...